MXL MAXLINEAR, INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 1288469 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY56.0%
TTM net income YoY83.6%
TTM EPS YoY84.2%
Revenue 3-yr CAGR-8.4%
Net income 3-yr CAGR—
Margins
Gross margin58.0%
Operating margin-0.9%
Net margin-4.4%
FCF margin-3.1%
EBITDA margin4.9%
Returns
ROE-5.9%
ROA-3.4%
ROIC (approx.)-0.9%
Asset turnover0.77x
Leverage & solvency
Liabilities / assets41.8%
Debt / equity0.31x
Current ratio2.22x
Interest coverage-0.63x
Cash quality & payout
Operating cash flow / net income0.25x
Accruals ratio-2.6%
Payout ratio—
Capex / revenue2.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $467.64M | $360.53M |
| Cost of revenue | $201.83M | $165.75M |
| Gross profit | $265.81M | $194.78M |
| R&D expense | $208.60M | $225.19M |
| SG&A expense | $159.58M | $138.33M |
| Operating income | -$126.89M | -$223.35M |
| Interest expense | $10.06M | $10.87M |
| Pretax income | -$140.89M | -$238.72M |
| Income tax | -$4.21M | $6.48M |
| Net income | -$136.68M | -$245.20M |
| EBITDA | -$82.90M | -$169.21M |
| EPS (basic) | -1.58 | -2.93 |
| EPS (diluted) | -1.58 | -2.93 |
| Weighted avg. shares (diluted) | 86.59M | 83.60M |
| Balance sheet | ||
| Cash & equivalents | $72.81M | $119.60M |
| Receivables | $46.12M | $85.46M |
| Inventory | $78.10M | $90.34M |
| Current assets | $248.84M | $323.44M |
| PP&E, net | $48.87M | $59.30M |
| Goodwill | $318.59M | $318.59M |
| Intangibles | $48.89M | $55.01M |
| Total assets | $796.40M | $864.64M |
| Current liabilities | $186.02M | $182.28M |
| Short-term debt | $0 | — |
| Long-term debt | $123.62M | $123.00M |
| Total debt | $123.62M | $123.00M |
| Total liabilities | $344.50M | $348.36M |
| Shareholders' equity | $451.89M | $516.28M |
| Net debt | $50.81M | $3.39M |
| Shares outstanding | 86.45M | 84.61M |
| Cash flow statement | ||
| Operating cash flow | $19.62M | -$45.30M |
| Capital expenditure | $12.60M | $17.68M |
| Free cash flow | $7.02M | -$62.98M |
| Investing cash flow | -$19.80M | -$23.45M |
| Financing cash flow | -$18.66M | $1.29M |
| Depreciation & amortization | $43.99M | $54.14M |
| Stock-based compensation | $77.13M | $66.02M |
| Share buybacks | $20.00M | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.